Accordingly, inflammation in SLE could be synergistically reduced by concurrent upregulation of TNFAIP3 and downregulation of UBE2L3, and an inclusion of this synergistic genetic effect in weighted genetic risk score would improve SLE risk prediction. The gene discussed is UBE2L3; the disease is systemic lupus erythematosus.